» Articles » PMID: 27911870

MiR-146a Polymorphism Correlates with Lung Cancer Risk in Chinese Nonsmoking Females

Overview
Journal Oncotarget
Specialty Oncology
Date 2016 Dec 3
PMID 27911870
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

This study provides evidence that the common rs2910164 polymorphism in miR-146a strongly correlates with lung cancer risk in nonsmoking females in northeast China. The genotypes of miR-146a rs2910164 were determined in 1131 patients with lung cancer and 1003 healthy control subjects. Tissue samples were used to evaluate the association between miRNA expression and lung cancer risk as well as the correlation between rs2910164 genotypes and miR-146a expression. The secondary structures of the wild-type and variant miR-146a sequences were predicted, and luciferase-based target assays were used to test whether miR-146a bound to tumor necrosis factor receptor associated factor 6 (TRAF6) mRNA. Individuals carrying heterozygous CG genotype of miR-146a rs2910164 had less risk of lung cancer than those carrying homozygous wild CC genotype (OR = 0.76, 95% CI = 0.60-0.98, P = 0.032). We found no significant association between miR-146a expression and lung cancer risk. MiR-146a expression differed in those carrying the CC genotype as compared with the CG or the GG genotype (P = 0.032 and 0.001), and the secondary structure of the C allele differed slightly from the G allele. Significantly lower levels of luciferase activity were observed when the TRAF6 3'UTR was cotransfected with miR-146a-3p carrying the rs2910164 C allele (P = 0.001). Thus, miR-146a rs2910164 polymorphism may influence susceptibility to lung cancer in Chinese nonsmoking females through targeting TRAF6.

Citing Articles

MiRNAs in Lung Cancer: Diagnostic, Prognostic, and Therapeutic Potential.

Wani J, Majid S, Imtiyaz Z, Rehman M, Alsaffar R, Shah N Diagnostics (Basel). 2022; 12(7).

PMID: 35885514 PMC: 9322918. DOI: 10.3390/diagnostics12071610.


Non-Coding RNA Polymorphisms (rs2910164 and rs1333049) Associated With Prognosis of Lung Cancer Under Platinum-Based Chemotherapy.

Chen Y, Chen J, Yin J, Zhou H, He B, Liu Z Front Pharmacol. 2021; 12:709528.

PMID: 34603024 PMC: 8481925. DOI: 10.3389/fphar.2021.709528.


Association between microRNA-146a, -499a and -196a-2 SNPs and non-small cell lung cancer: a case-control study involving 2249 subjects.

Qiu H, Xie Z, Tang W, Liu C, Wang Y, Gu H Biosci Rep. 2021; 41(2).

PMID: 33554246 PMC: 7890400. DOI: 10.1042/BSR20201158.


The miR-146a SNP Rs2910164 and miR-155 SNP rs767649 Are Risk Factors for Non-Small Cell Lung Cancer in the Iranian Population.

Dezfuli N, Adcock I, Alipoor S, Seyfi S, Salimi B, Golchin M Can Respir J. 2020; 2020:8179415.

PMID: 33294082 PMC: 7700047. DOI: 10.1155/2020/8179415.


In vivo miRNA knockout screening identifies miR-190b as a novel tumor suppressor.

Hong H, Yao S, Zhang Y, Ye Y, Li C, Hu L PLoS Genet. 2020; 16(11):e1009168.

PMID: 33137086 PMC: 7660552. DOI: 10.1371/journal.pgen.1009168.


References
1.
Wakelee H, Chang E, Gomez S, Keegan T, Feskanich D, Clarke C . Lung cancer incidence in never smokers. J Clin Oncol. 2007; 25(5):472-8. PMC: 2764546. DOI: 10.1200/JCO.2006.07.2983. View

2.
Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M . Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell. 2006; 9(3):189-98. DOI: 10.1016/j.ccr.2006.01.025. View

3.
Tian T, Shu Y, Chen J, Hu Z, Xu L, Jin G . A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese. Cancer Epidemiol Biomarkers Prev. 2009; 18(4):1183-7. DOI: 10.1158/1055-9965.EPI-08-0814. View

4.
Bloomston M, Frankel W, Petrocca F, Volinia S, Alder H, Hagan J . MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA. 2007; 297(17):1901-8. DOI: 10.1001/jama.297.17.1901. View

5.
Yang L, Parkin D, Li L, Chen Y . Time trends in cancer mortality in China: 1987-1999. Int J Cancer. 2003; 106(5):771-83. DOI: 10.1002/ijc.11300. View